Download Sample
Add to CartHeart-lung Machines Market
By Component;
Oxygenators, Pumps and CannulaBy End-User;
Hospitals and Cardiac CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Heart-lung Machines Overview
Heart-lung Machines Market (USD Million)
Heart-lung Machines Market was valued at USD 413.16 million in the year 2024. The size of this market is expected to increase to USD 629.49 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.
Heart-lung Machines Market
*Market size in USD million
CAGR 6.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.2 % |
| Market Size (2024) | USD 413.16 Million |
| Market Size (2031) | USD 629.49 Million |
| Market Concentration | Medium |
| Report Pages | 304 |
Major Players
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Sorin Group (Now part of LivaNova PLC)
- MAQUET Holding B.V. & Co. KG (A subsidiary of Getinge AB)
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Heart-lung Machines Market
Fragmented - Highly competitive market without dominant players
The Heart-lung Machines Market continues to experience consistent growth, driven by its indispensable role in cardiac surgeries where circulatory and respiratory support is required. These machines safeguard patients during complex operations by maintaining vital functions with precision and reliability. Currently, nearly 65% of open-heart procedures depend on heart-lung machines, reinforcing their critical contribution to advanced surgical care and patient outcomes.
Growing adoption of surgical support systems
With cardiovascular diseases on the rise, there is an increasing demand for efficient surgical support devices, making heart-lung machines a cornerstone of cardiac procedures. Approximately 55% of heart surgeries now incorporate sophisticated extracorporeal circulation systems, reflecting their expanding role in ensuring surgical safety. This trend is strengthening as healthcare providers seek solutions that deliver both improved outcomes and operational efficiency in operating rooms.
Innovations shaping extracorporeal technologies
Technological innovation remains at the core of the heart-lung machines market, as manufacturers integrate digital interfaces, automated controls, and advanced sensors into new systems. Around 40% of the latest devices highlight enhanced monitoring capabilities, giving surgeons improved precision during critical procedures. These innovations not only support better patient survival rates but also streamline surgical processes, emphasizing the importance of continuous product development.
Strategic collaborations driving advancements
Industry collaborations, mergers, and partnerships are significantly accelerating progress in this market. Nearly 30% of recently introduced devices originate from joint ventures, underlining the growing focus on shared expertise and innovation. These strategies are helping broaden access to reliable technologies while fostering a competitive environment that encourages continuous improvements in surgical care.
Positive growth outlook
The heart-lung machines market is positioned for long-term expansion as hospitals and cardiac centers prioritize modernization of surgical infrastructure. More than 45% of specialized treatment facilities are actively upgrading to advanced extracorporeal systems, signaling sustained adoption. The blend of rising procedure volumes, technological progress, and strong industry partnerships ensures that this market will maintain a promising growth trajectory in the years ahead.
Heart-lung Machines Market Recent Developments
-
In September 2022, LivaNova received FDA 510(k) clearance for its Essenz heart-lung machine (HLM), allowing the company to launch it commercially in the U.S. Essenz HLM has also been approved by Health Canada and the Japanese PMDA. Earlier, LivaNova introduced Essenz in Europe through a limited commercial launch.
-
In March 2023, LivaNova announced that they had received the U.S. FDA 510(k) clearance for their Essenz heart-lung machine intended for cardiopulmonary bypass (CPB) procedures. This machine is incorporated with advanced cable management and components for smooth user interface and better clinical results. This regulatory approval helped the company to enhance their R&D capabilities and increase their business revenue.
Heart-lung Machines Market Segment Analysis
In this report, the Heart-lung Machines Market has been segmented by Type,Component, Application, End-User and Geography.
Heart-lung Machines Market, Segmentation by Type
The Heart-lung Machines Market has been segmented by Type into Single Roller Pump and Double Roller Pump.
Single Roller Pump
Single roller pumps are commonly used in heart-lung machines because they are simple and cost-effective. They ensure a steady blood flow during cardiac surgeries, which makes them popular in routine procedures, representing about 55–60% of the market. Their low maintenance and reliable performance make them a frequent choice in many hospitals worldwide.
Double Roller Pump
Double roller pumps are designed for safety and reliability, suitable for more complex cardiac procedures. They can maintain circulation even if one pump fails, making them important in specialized cardiac care, with a market share of around 30–35%. These pumps are valued for their precision and consistent performance, particularly during long surgeries.
Heart-lung Machines Market, Segmentation by Component
The Heart-lung Machines Market has been segmented by Component into Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, and OthersOxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, and Others
Oxygenators
Oxygenators are an important part of heart-lung machines, helping to provide oxygen to the blood during surgery. They are used in about 20–25% of procedures and are valued for improving patient safety. Modern designs aim to reduce blood damage and make gas exchange more efficient.
Pumps
Pumps help circulate blood through the heart-lung machine and are used in roughly 25–30% of cases. They keep blood flow steady, which is essential during surgery. Hospitals choose between single and double roller pumps depending on the complexity of the procedure.
Cannula
Cannulae connect the patient to the machine, allowing smooth blood transfer. They make up about 10–15% of the component market. Their design focuses on minimizing blood vessel injury and ensuring accurate placement.
Monitoring Systems
Monitoring systems track blood flow, pressure, and oxygen levels, helping the surgical team respond quickly. They account for around 8–10% of the market and are increasingly used in modern surgical units for better outcomes.
Heat Exchanger Units
Heat exchangers control blood temperature during surgery, which is important to avoid complications. They cover about 5–7% of the market and are often part of advanced heart-lung machines. Their main purpose is to keep the patient’s body temperature stable.
Blood Reservoir
Blood reservoirs temporarily store blood to ensure it keeps flowing to the patient. They represent roughly 5–6% of the market and help manage changes in blood volume and pressure. Modern reservoirs also minimize air exposure to keep blood safe.
Others
Other components like filters, tubing, and connectors make up about 10% of the market. While smaller individually, they are essential for the machine to work properly and keep patients safe.
Heart-lung Machines Market, Segmentation by Application
The Heart-lung Machines Market has been segmented by Application into Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others.
Cardiac Surgeries
Heart-lung machines are most widely used in cardiac surgeries, including bypass and valve procedures. This segment accounts for roughly 60–65% of the market due to the high demand for precise circulation and oxygenation support. Surgeons rely on these machines for safe and stable patient management during complex operations.
Lung Surgeries
In lung surgeries, heart-lung machines help maintain blood oxygenation and circulation while the lungs are being operated on. This application covers about 15–20% of the market, particularly in thoracic surgical centers. Machines used here are often specialized and adaptable to support both short and prolonged procedures.
Acute Respiratory Failure Treatment
Heart-lung machines are increasingly applied in treating acute respiratory failure, providing temporary extracorporeal support. This segment represents approximately 10–12% of the market, growing due to ICU adoption and critical care needs. These systems ensure oxygen delivery and circulation while the lungs recover.
Others
Other applications, including research, pediatric support, and emergency use, account for roughly 5–8% of the market. While smaller in scale, these uses are important for specialized patient care and innovative clinical procedures, where machine versatility is key.
Heart-lung Machines Market, Segmentation by End-User
The Heart-lung Machines Market has been segmented by End-User into ASCs and Hospitals.
ASCs
Ambulatory Surgical Centers (ASCs) are increasingly using heart-lung machines for minor to moderate cardiac procedures. They account for roughly 15–20% of the market, as these centers focus on efficiency and cost-effectiveness. ASCs benefit from compact, easy-to-use machines that allow safe procedures with shorter patient stays.
Hospitals
Hospitals remain the largest end-users of heart-lung machines, covering about 80–85% of the market. They handle complex cardiac surgeries requiring advanced machines and specialized teams. Hospitals value high-capacity, reliable systems that support a wide range of procedures and patient needs.
Heart-lung Machines Market, Segmentation by Geography
In this report, the Heart-lung Machines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Heart-lung Machines Market Share (%), by Geographical Region
North America
North America is the largest market for heart-lung machines, accounting for roughly 35–40% of global demand. The growth is driven by advanced healthcare infrastructure, rising cardiac surgeries, and increasing adoption of high-tech devices. The region benefits from strong regulatory support and high healthcare spending.
Europe
Europe holds around 25–30% of the market, with Germany, France, and the UK being major contributors. Demand is fueled by well-established cardiac care facilities and technologically advanced heart-lung systems. Increasing geriatric population and rising cardiovascular disease prevalence also drive growth.
Asia Pacific
Asia Pacific represents approximately 20–25% of the market, driven by emerging economies like India, China, and Japan. The growth is supported by rising cardiac surgeries, expanding healthcare access, and increasing awareness of advanced medical devices. Cost-effective solutions and growing hospital infrastructure further boost adoption.
Middle East and Africa
Middle East and Africa account for roughly 5–7% of the market. Growth is slower compared to other regions, but increasing investments in healthcare infrastructure and awareness of advanced cardiac procedures are supporting demand. Countries like Saudi Arabia, UAE, and South Africa are leading the adoption of heart-lung machines.
Latin America
Latin America contributes about 5–8% of the global market. Growth is driven by expanding healthcare services, government initiatives, and increasing cardiac surgery centers. Brazil and Mexico are the key markets, focusing on modernizing hospital equipment and improving patient care standards.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Heart-lung Machines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological Advancements
- Increasing Cardiovascular Surgeries
- Rising Prevalence of Heart Diseases
- Growing Aging Population
-
Surge in Organ Transplants : The surge in organ transplants has become a significant driver in the global heart-lung machines market. As advancements in medical science continue to improve the success rates of organ transplantation, there's a growing demand for heart-lung machines that can support these intricate procedures. With more individuals requiring life-saving organ transplants due to various health conditions such as heart failure or lung diseases, the need for reliable heart-lung machines has intensified. This surge in organ transplantation has not only increased the volume of surgeries but has also expanded the market for heart-lung machine manufacturers and suppliers.
The increasing acceptance and success of heart-lung transplantation as a viable treatment option for end-stage cardiac and pulmonary diseases have fueled the demand for heart-lung machines worldwide. Patients suffering from conditions that were previously deemed untreatable now have hope through organ transplantation, driving both healthcare providers and medical device manufacturers to invest more in this field. Additionally, advancements in organ procurement techniques, preservation methods, and surgical procedures have contributed to the growing number of organ transplants, further boosting the requirement for efficient heart-lung machines during these procedures.
The global rise in awareness about organ donation and transplantation, coupled with government initiatives and healthcare campaigns, has led to a significant increase in organ procurement rates. As more individuals and families consent to organ donation, the pool of available organs for transplantation expands, consequently driving the demand for heart-lung machines to support these surgeries. This surge in organ transplants not only saves lives but also presents a lucrative opportunity for stakeholders in the heart-lung machines market to innovate and develop advanced technologies that can further enhance the success and efficiency of organ transplantation procedures.
Restraints
- High Cost of Equipment
- Stringent Regulatory Policies
- Limited Access in Remote Areas
- Risk of Infections
-
Lack of Skilled Professionals : The lack of skilled professionals presents a significant challenge in the global heart-lung machines market, hindering the efficient operation and utilization of these critical medical devices. Heart-lung machines require specialized knowledge and training to operate effectively during complex cardiovascular surgeries. However, there is a shortage of healthcare professionals with the necessary expertise in handling these machines, including perfusionists who manage the circulation of blood and oxygen during procedures. This shortage can lead to inefficiencies in operating theaters, delays in surgeries, and increased risks for patients undergoing cardiovascular procedures.
The complexity of heart-lung machines necessitates ongoing education and training for healthcare professionals to stay updated with the latest advancements and best practices in perfusion technology. However, limited access to specialized training programs and resources exacerbates the shortage of skilled professionals in this field. As a result, healthcare institutions may struggle to recruit and retain qualified perfusionists, further exacerbating the problem and impacting the quality of care provided to patients requiring heart-lung support during surgeries.
Addressing the lack of skilled professionals in the heart-lung machines market requires collaborative efforts from healthcare organizations, educational institutions, and industry stakeholders. Investing in comprehensive training programs, continuing education initiatives, and mentorship opportunities can help cultivate a skilled workforce capable of proficiently operating and maintaining heart-lung machines. Additionally, leveraging technology such as simulation training and virtual reality platforms can enhance the learning experience and bridge the gap between theory and practical application. By prioritizing education and professional development in perfusion technology, healthcare systems can mitigate the challenges posed by the lack of skilled professionals and ensure optimal outcomes for patients undergoing cardiovascular surgeries.
Opportunities
- Innovations in Product Design
- Collaborations with Research Institutions
- Market Expansion in Developing Regions
- Customization for Specific Patient Needs
-
Focus on Portable Solutions : The growing focus on portable solutions in the global heart-lung machines market reflects a shift towards enhancing accessibility and flexibility in critical care settings. Traditional heart-lung machines are often large, stationary units that require dedicated space within hospitals or surgical centers. However, the demand for portable solutions has emerged due to the need for more versatile and mobile devices that can be deployed in various healthcare environments, including operating rooms, emergency departments, and transport vehicles. Portable heart-lung machines offer healthcare providers the flexibility to perform complex cardiovascular procedures in diverse settings, enabling timely intervention and improved patient outcomes.
Advancements in miniaturization technology and engineering have paved the way for the development of compact and lightweight portable heart-lung machines that maintain the same level of performance and functionality as their larger counterparts. These portable solutions are designed to be easily transportable and deployable, allowing for rapid setup and operation during emergency situations or in resource-limited settings. Additionally, portable heart-lung machines offer greater maneuverability and versatility, enabling healthcare providers to deliver life-saving care to patients across various clinical scenarios, including intra-hospital transfers and remote medical missions.
The adoption of portable heart-lung machines is driven by the growing trend towards minimally invasive surgical techniques and ambulatory care models. As healthcare delivery continues to evolve towards patient-centered care and shorter hospital stays, portable heart-lung machines enable clinicians to perform complex cardiac procedures with greater efficiency and reduced invasiveness. By offering greater mobility and adaptability, portable solutions empower healthcare providers to deliver high-quality cardiovascular care while maximizing resource utilization and improving overall patient satisfaction. As such, the focus on portable solutions represents a significant advancement in the global heart-lung machines market, with potential implications for transforming the landscape of cardiac surgery and critical care delivery.
Competitive Landscape Analysis
Key players in Global Heart-lung Machines Market include:
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Sorin Group (Now part of LivaNova PLC)
- MAQUET Holding B.V. & Co. KG (A subsidiary of Getinge AB)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Heart-lung Machines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements
- Increasing Cardiovascular Surgeries
- Rising Prevalence of Heart Diseases
- Growing Aging Population
- Surge in Organ Transplants
- Restraints
- High Cost of Equipment
- Stringent Regulatory Policies
- Limited Access in Remote Areas
- Risk of Infections
- Lack of Skilled Professionals
- Opportunities
- Innovations in Product Design
- Collaborations with Research Institutions
- Market Expansion in Developing Regions
- Customization for Specific Patient Needs
- Focus on Portable Solutions
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
-
Heart-lung Machines Market, By Component, 2021 - 2031 (USD Million)
-
Oxygenators
-
Pumps
-
Cannula
-
- Heart-lung Machines Market, By End-User, 2021 - 2031 (USD Million)
- Hospitals
- Cardiac Centers
- Heart-lung Machines Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
-
- Competitive Landscape
- Company Profiles
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- Sorin Group (Now part of LivaNova PLC)
- MAQUET Holding B.V. & Co. KG (A subsidiary of Getinge AB)
- Company Profiles
- Analyst Views
- Future Outlook of the Market